Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

How our clients use DrugPatentWatch

Generated: April 28, 2017

DrugPatentWatch Database Preview

Details for Patent: 5,648,333

« Back to Dashboard

Which drugs does patent 5,648,333 protect, and when does it expire?

Patent 5,648,333 protects FIRAZYR and is included in one NDA. There has been one Paragraph IV challenge on Firazyr.

This patent has one hundred and twelve patent family members in thirty-three countries.

Summary for Patent: 5,648,333

Title: Peptides having bradykinin antagonist action
Abstract:Peptides of the formula I wherein the terms A, B, C, E, F, K, P, G, M, F', and I are defined in the specification, have bradykinin antagonist action. Their therapeutic utility includes all pathological states which are mediated, caused or supported by bradykinin and bradykinin-related peptides.
Inventor(s): Henke; Stephan (Hofheim am Taunus, DE), Anagnostopulos; Hiristo (Wiesbaden, DE), Breipohl; Gerhard (Frankfurt am Main, DE), Knolle; Jochen (Kriftel, DE), Stechl; Jens (Frankfurt am Main, DE), Scholkens; Bernward (Kelkeim/Taunus, DE), Fehlhaber; Hans-Wolfram (Idstein, DE), Gerhards; Hermann (Hofheim am Taunus, DE), Hock; Franz (Dieburg, DE)
Assignee: Hoechst Aktiengesellschaft (Frankfurt am Main, DE)
Application Number:08/487,442
Patent Claim Types:
see list of patent claims
Compound; Use; Composition;

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use
Shire Orphan Therap
icatibant acetate
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Foreign Priority and PCT Information for Patent: 5,648,333

Foriegn Application Priority Data
Foreign Country Foreign Patent Number Foreign Patent Date
Germany38 39 581.9Nov 24, 1988
Germany39 16 291.5May 19, 1989
Germany39 26 225.8Jun 03, 1989
Germany39 26 822.5Aug 14, 1989
Germany40 13 270.6Apr 26, 1990

International Patent Family for Patent: 5,648,333

Country Document Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
Finland94353► Subscribe
Finland102759► Subscribe
Finland911978► Subscribe
Finland109541► Subscribe
Greece3023172► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

The estimated expiration dates shown above are derived by simply adding 20 years to the priority date.
Due to the complexity of determining patent expirations even in a single country, compounded by the diversity of global patent laws, it is advisable to have patent counsel verify freedom to operate.

Export unavailable in trial.
Subscribe for complete access.

For more information try a trial or see the database preview and plans and pricing

How our clients use DrugPatentWatch

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted

Follow DrugPatentWatch:

Google Plus